Skip to main content

Contracts flowing from multiple sectors

SXE has provided two contract award updates within a week, with new contracts awarded across multiple sectors and by repeat clients totalling >$225m. We are pleased to see further contract awards in the Data Centre sector and an additional Healthcare work package to be delivered in the Illawarra region. Key points:

Orderbook bolstered: Excluding the ~$50m Collie BESS Project Switchyard construction package awarded on 5 July 2024, SXE has announced >$225m of new contract awards in FY25-to date, including purchase orders at Trivantage Manufacturing. These orders compare with >$140m of contracts awarded in the PcP and ~$470m in FY24 (including $210m of work packages for the Collie BESS project and switchyard). We expect SXE to deliver a 1H FY25 orderbook that is consistent with the record $720m reported at FY24, accounting for increased project delivery in 1H FY25, with revenue to lift 23% YoY to $314m.

FY25 EBITDA guidance: SXE continue to anticipate FY25 EBITDA of at least $53.0m (BPe $54.2m, implying >21% YoY growth). While FY25-to-date contract awards are encouraging for expected activity growth across the Group, we do anticipate a high level of work replenishment as contracts complete over FY25, maintaining an elevated EBITDA run-rate into FY26 (vs FY24: $40.1m). We see upside to our forecasts should FY25-to-date contract award momentum continue in 2H FY25.

EPS changes reflect a more optimistic medium-term view of Infrastructure project delivery: nc in FY25-26; and +7% in FY27.

Investment thesis: Buy; TP$2.25/sh (unchanged)

SXE brings key small cap exposure to several emerging and structural themes, including the proliferation of data centre construction across Australia, decarbonisation of the Australian economy, electrification of industries and the build-out of large-scale critical infrastructure. SXE’s blue-chip clientele and high proportion of recurring work (33% of FY24 Group revenue) provides some stability to operations and financials and reduced counterparty risk.

To read the full report click the button below.

View Detailed Report
Authored by Joseph House – Analyst – at Bell Potter Securities, 16 December 2024
Important Disclaimer—This may affect your legal rights: Because this document has been prepared without consideration of any specific client’s financial situation, particular needs and investment objectives, a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the proper authority of such licensee, who has provided you with this report by arrangement with Bell Potter Securities Limited) should be consulted before any investment decision is made. While this document is based on the information from sources which are considered reliable, Bell Potter Securities Limited, its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility to inform you of any matter that subsequently comes to its notice, which may affect any of the information contained in this document. This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. This is general investment advice only and does not constitute advice to any person.
Disclosure of Interest: Bell Potter Securities Limited receives commission from dealing in securities and its authorised representatives, or introducers of business, may directly share in this commission. Bell Potter Securities and its associates may hold shares in the companies recommended.